Hence, the anti-leukemic effect of acadesine on K562 cells and CD34+ progenitor was long-standing and thus, we decided to test this compound on CML tumor formation in mice. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.